Corticosteroid, Platelet-Rich Plasma, and Ozone Injections for Sinus Tarsi Syndrome
Yazarlar (4)
Serdar Toy
Ağrı Training And Research Hospital, Türkiye
Ağrı Training And Research Hospital, Türkiye
Doç. Dr. Kutsi Tuncer Ataturk University, Faculty Of Medicine, Türkiye
Doç. Dr. Murat TOPAL Kastamonu Üniversitesi, Türkiye
Prof. Dr. Ali Aydin Ataturk University, Faculty Of Medicine, Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Journal of the American Podiatric Medical Association (Q4) | ||
| Dergi ISSN | 8750-7315 Wos Dergi Scopus Dergi | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2023 |
| Cilt / Sayı / Sayfa | 113 / 1 / – | DOI | 10.7547/20-221 |
| Makale Linki | https://japmaonline.org/view/journals/apms/aop/20-221/20-221.xml?alreadyAuthRedirecting | ||
| Özet |
| Background: Sinus tarsi syndrome is characterized by permanent pain on the anterolateral side of the ankle due to chronic inflammation characterized by fibrotic tissue remnants and synovitis accumulation after repeated traumatic injuries. Few studies have documented the outcome of injection treatments for sinus tarsi syndrome. We sought to determine the effects of corticosteroid and local anesthetic (CLA), platelet-rich plasma (PRP), and ozone injections on sinus tarsi syndrome.Methods: Sixty patients with sinus tarsi syndrome were randomly divided into three treatment groups: CLA, PRP, and ozone injections. Outcome measures were visual analog scale, American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale (AOFAS), Foot Function Index, and Foot and Ankle Outcome Score before injection compared with 1, 3, and 6 months after injection.Results: At the end of months 1, 3, and 6 after injection … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 1 |
| Scopus | 2 |
| Google Scholar | 4 |